Part 1: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML

Video

Alexandra S. Wolff, PharmD, BCOP, discusses use of IDH1 and IDH2 inhibitors in newly diagnosed AML patients and highlights recently released trial data.

Related Videos
Patient preparing to undergo dialysis
© 2023 MJH Life Sciences

All rights reserved.